Lindheim S R, Notelovitz M, Feldman E B, Larsen S, Khan F Y, Lobo R A
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
Obstet Gynecol. 1994 Feb;83(2):167-72.
To assess the effects of a moderate exercise program with and without oral estrogen replacement on levels of lipids and lipoproteins in postmenopausal women.
One hundred one postmenopausal women were randomized into four groups: control or sedentary (N = 20), exercise alone (N = 25), estrogen replacement using 0.625 mg conjugated equine estrogen (N = 28), and exercise supplemented with conjugated equine estrogen (N = 28). The exercise groups were placed on a moderate exercise program. Following baseline testing, each group returned at 3 and 6 months for cardiorespiratory fitness testing and serum lipid and lipoprotein profiles.
We found a significant decrease in systolic blood pressure (P < .05) in all treatment groups. The maximum oxygen uptake increased by 9.0 and 7.8% in the exercise and conjugated equine estrogen/exercise groups, respectively, compared to the other groups (P < .05). These responses were seen at both 3 and 6 months. Total exercise time (time spent on the treadmill until exhaustion during testing) significantly increased in the exercise group by 21% (P < .01). Exercise alone was associated with significant decreases in total cholesterol (5.2%, P < .05), triglycerides (2%, P < .05), and low-density lipoprotein (LDL) cholesterol (10%, P < .01), and a significant increase in the high-density lipoprotein (HDL) cholesterol-LDL ratio (17.2%, P < .01). Significant changes were noted in these values, as well as increases in HDL cholesterol (16 and 14.8%; P < .01) and apolipoprotein A1 (25.6 and 26.5%; P < .001) in the conjugated equine estrogen and conjugated equine estrogen/exercise groups, respectively. However, there were no differences in the changes observed in the conjugated equine estrogen groups with versus without exercise. No direct correlation was seen between measures of exercise performance and the changes seen in lipids and lipoproteins.
Estrogen therapy alone had the greatest beneficial effect on lipids and lipoproteins. Exercise alone resulted in a significant reduction in cholesterol, triglycerides, and LDL cholesterol, and an increase in the HDL-LDL ratio. However, combined conjugated equine estrogen and exercise did not demonstrate an added improvement in lipid metabolism. Physical fitness levels increased in the exercise groups, but not in the control group or the estrogen-alone treated women.
评估适度运动计划联合或不联合口服雌激素替代疗法对绝经后女性血脂和脂蛋白水平的影响。
101名绝经后女性被随机分为四组:对照组或久坐组(N = 20)、单纯运动组(N = 25)、使用0.625毫克结合马雌激素进行雌激素替代治疗组(N = 28)以及结合马雌激素补充运动组(N = 28)。运动组进行适度运动计划。在基线测试后,每组在3个月和6个月时返回进行心肺适能测试以及血脂和脂蛋白谱检测。
我们发现所有治疗组的收缩压均显著降低(P < 0.05)。与其他组相比,运动组和结合马雌激素/运动组的最大摄氧量分别增加了9.0%和7.8%(P < 0.05)。在3个月和6个月时均观察到了这些变化。运动组的总运动时间(测试期间在跑步机上直至疲惫的时间)显著增加了21%(P < 0.01)。单纯运动与总胆固醇显著降低(5.2%,P < 0.05)、甘油三酯降低(2%,P < 0.05)以及低密度脂蛋白(LDL)胆固醇降低(10%,P < 0.01)相关,并且高密度脂蛋白(HDL)胆固醇与LDL的比值显著增加(17.2%,P < 0.01)。在结合马雌激素组和结合马雌激素/运动组中,这些值出现了显著变化,同时HDL胆固醇分别增加了16%和14.8%(P < 0.01),载脂蛋白A1分别增加了25.6%和26.5%(P < 0.001)。然而,在结合马雌激素组中,运动组与非运动组在观察到的变化方面没有差异。运动表现指标与血脂和脂蛋白变化之间未发现直接相关性。
单独使用雌激素疗法对血脂和脂蛋白具有最大的有益作用。单纯运动导致胆固醇、甘油三酯和LDL胆固醇显著降低,以及HDL与LDL比值增加。然而,结合马雌激素与运动联合使用并未显示出在脂质代谢方面有额外改善。运动组的体能水平有所提高,但对照组和单纯接受雌激素治疗的女性则没有。